Jeffrey Peter Armitstead

Title: Jeffrey Peter Armitstead: Innovator in Sleep Apnea Diagnosis

Introduction

Jeffrey Peter Armitstead is a notable inventor based in Bella Vista, Australia. He has made significant contributions to the field of medical diagnostics, particularly in the area of sleep apnea. His innovative approach combines advanced imaging techniques to enhance the diagnosis of obstructive sleep apnea.

Latest Patents

Armitstead holds a patent for a method known as the Tongue Fat Screening Assay. This patent provides methods for diagnosing or predicting the likelihood of a subject experiencing obstructive sleep apnea. The diagnosis is determined at least in part by measuring the degree of tongue fat in a subject using techniques such as thermal imaging, THz imaging, or other multispectral imaging. He has 1 patent to his name.

Career Highlights

Jeffrey Armitstead is associated with ResMed Sensor Technologies Limited, a company that focuses on innovative solutions for sleep and respiratory disorders. His work at ResMed has allowed him to contribute to advancements in medical technology that aim to improve patient outcomes.

Collaborations

Throughout his career, Armitstead has collaborated with talented professionals in his field, including Redmond Shouldice and Jose Ricardo Dos Santos. These collaborations have fostered an environment of innovation and have led to the development of cutting-edge diagnostic methods.

Conclusion

Jeffrey Peter Armitstead is a pioneering inventor whose work in sleep apnea diagnosis exemplifies the intersection of technology and healthcare. His contributions continue to influence the medical field and improve the lives of patients suffering from sleep disorders.